- ►diabetesjournals.org Z Ling, Q Wang, G Stangé… - Diabetes, 2006 - Am Diabetes Assoc Use of sulfonylureas in diabetes treatment is based on their insulin-releasing
effect on pancreatic β-cells. Prolonged action is known to degranulate
β-cells, but functional consequences have not been examined at the ... Cited by 2 - Related articles - BL Direct - All 5 versions
Z Ling, Q Wang, G Stangee - 糖尿病学杂志, 2006 - journal.shouxi.net Use of sulfonylureas in diabetes treatment is based on their insulin-releasing
effect on pancreatic -cells. Prolonged action is known to degranulate -cells,
but functional consequences have not been examined at the cellular level. ... Related articles - Cached
[CITATION] Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose …
G Martens, Y Cai, S Hinke, G Stang, M … - Biochemical Society Transactions, 2005 - bst.portlandpress.com Excessively high glucose concentrations have been shown to damage tissues
through stimulation of mitochondrial superoxide generation. This effect has
therefore been considered as a potential cause for dysfunction and death of ... Cited by 4 - Related articles - Cached - All 10 versions
K Hellemans, K Kerckhofs, JC Hannaert, G … - FEBS J, 2007 - interscience.wiley.com Fatty acids can stimulate the secretory activity of insulin-producing
beta-cells. At elevated concentrations, they can also be toxic to isolated
beta-cells. This toxicity varies inversely with the cellular ability to ... Cited by 4 - Related articles - BL Direct - All 5 versions
D Jia, M Otsuki - Pancreas, 2003 - journals.lww.com Address correspondence and reprint requests to Makoto Otsuki, MD, PhD, Third
Department of Internal Medicine, University of Occupational and Environmental
Health, Japan, School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, ... Cited by 6 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org F Kamp, N Kizilbash, BE Corkey, PO Berggren … - Diabetes, 2003 - Am Diabetes Assoc Because sulfonylureas directly activate the exocytotic machinery, we were
interested in the extent to which these compounds penetrate the β-cell plasma
membrane and the underlying molecular mechanism(s). We now provide evidence ... Cited by 16 - Related articles - BL Direct - All 4 versions
- ►unige.ch [PDF] F Frigerio, G Chaffard, M Berwaer, P Maechler - Biochemical pharmacology, 2006 - Elsevier Topiramate (Topamax), primarily prescribed against epilepsy, was reported to
reduce body weight and to ameliorate glycemic control in obese patients with
diabetes. In rodent models of obesity and diabetes, topiramate treatment ... Cited by 8 - Related articles - All 5 versions
[CITATION] In't Veld P, Pipeleers D (2006) Glibenclamide treatment recruits beta-cell subpopulation into …
